These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 926843

  • 61. Recurrent urinary tract infections in premenopausal women: prophylaxis based on an understanding of the pathogenesis.
    Pfau A, Sacks T, Engelstein D.
    J Urol; 1983 Jun; 129(6):1153-7. PubMed ID: 6682903
    [Abstract] [Full Text] [Related]

  • 62. Antimicrobial susceptibility of Staphylococcus saprophyticus and urethral staphylococci.
    Marrie TJ, Kwan C.
    Antimicrob Agents Chemother; 1982 Sep; 22(3):395-7. PubMed ID: 6982679
    [Abstract] [Full Text] [Related]

  • 63. Synergistic activity of co-trimazine and co-trimoxazole in the urine.
    Acar J, Ekström B, Fellner H, Forsgren U, Guibert J, Huitfeldt B, Kitzis MD, Magni L, Ortengren B.
    Infection; 1979 Sep; 7 Suppl 4():S324-9. PubMed ID: 389809
    [Abstract] [Full Text] [Related]

  • 64. In vitro activity of trimethoprim against Borrelia burgdorferi.
    Reisinger EC, Wendelin I, Gasser R.
    Eur J Clin Microbiol Infect Dis; 1997 Jun; 16(6):458-60. PubMed ID: 9248750
    [Abstract] [Full Text] [Related]

  • 65. Antibacterial activity of co-trimazine in vitro and in vivo.
    Ekström B, Fellner H, Forsgren U, Magni L, Ortengren B.
    Infection; 1979 Jun; 7(2):74-80. PubMed ID: 374276
    [Abstract] [Full Text] [Related]

  • 66. Optimizing dosing of nitrofurantoin from a PK/PD point of view: What do we need to know?
    Wijma RA, Fransen F, Muller AE, Mouton JW.
    Drug Resist Updat; 2019 Mar; 43():1-9. PubMed ID: 30947111
    [Abstract] [Full Text] [Related]

  • 67. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 2: Comparative pharmacokinetics of five sulphonamides.
    Ortengren B, Fellner H, Bergan T.
    Infection; 1979 Mar; 7 Suppl 4():S367-70. PubMed ID: 511350
    [Abstract] [Full Text] [Related]

  • 68. Review of adverse reactions associated with cinoxacin and other drugs used to treat urinary tract infections.
    Burt RA.
    Urology; 1984 Jan; 23(1):101-7. PubMed ID: 6362163
    [Abstract] [Full Text] [Related]

  • 69. Increases in rates of resistance to trimethoprim.
    Huovinen P.
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S63-6. PubMed ID: 8994780
    [Abstract] [Full Text] [Related]

  • 70. Studies on the in vitro development of drug resistance of Proteeae to sulfonamides, trimethoprim and combinations of a sulfonamide and trimethoprim.
    Grunberg E, Beskid G.
    Chemotherapy; 1977 Jan; 23(5):309-13. PubMed ID: 332463
    [Abstract] [Full Text] [Related]

  • 71. Studies on cinoxacin. 1. In vitro activity of cinoxacin, as compared to nalidixic acid, against urinary tract pathogens.
    Mårdh PA, Collen S, Andersson KE.
    J Antimicrob Chemother; 1977 Sep; 3(5):411-6. PubMed ID: 903323
    [No Abstract] [Full Text] [Related]

  • 72. Variation by specialty in the treatment of urinary tract infection in women.
    Wigton RS, Longenecker JC, Bryan TJ, Parenti C, Flach SD, Tape TG.
    J Gen Intern Med; 1999 Aug; 14(8):491-4. PubMed ID: 10491234
    [Abstract] [Full Text] [Related]

  • 73. Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections.
    Thomas FE, Leonard JM, Alford RH.
    Antimicrob Agents Chemother; 1976 Feb; 9(2):201-7. PubMed ID: 178273
    [Abstract] [Full Text] [Related]

  • 74. Lack of influence of co-trimoxazole on theophylline pharmacokinetics.
    Jonkman JH, Van der Boon WJ, Schoenmaker R, Holtkamp AH, Hempenius J.
    J Pharm Sci; 1985 Oct; 74(10):1103-4. PubMed ID: 3878403
    [Abstract] [Full Text] [Related]

  • 75. Bioevaluation of the antibacterial flumequine for urinary tract use.
    Rohlfing SR, Gerster JR, Kvam DC.
    Antimicrob Agents Chemother; 1976 Jul; 10(1):20-4. PubMed ID: 984753
    [Abstract] [Full Text] [Related]

  • 76. The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.
    Reeves DS, Wilkinson PJ.
    Infection; 1979 Jul; 7 Suppl 4():S330-41. PubMed ID: 389810
    [Abstract] [Full Text] [Related]

  • 77. In vitro studies with combinations of sulfamoxole and trimethoprim (co-trifamole).
    Grüneberg RN.
    Curr Med Res Opin; 1982 Jul; 8(2):128-33. PubMed ID: 7105824
    [Abstract] [Full Text] [Related]

  • 78. An update on the role of nitrofurans in the management of urinary tract infections.
    Guay DR.
    Drugs; 2001 Jul; 61(3):353-64. PubMed ID: 11293646
    [Abstract] [Full Text] [Related]

  • 79. Comparison of dihydrofolate reductases from trimethoprim- and sulfonamide-resistant strains of Neisseria gonorrhoeae.
    Ho RI, Lai PH, Corman L, Ho J, Morse SA.
    Sex Transm Dis; 1978 Jul; 5(2):43-50. PubMed ID: 10328030
    [Abstract] [Full Text] [Related]

  • 80. Oral antibiotics for febrile urinary tract infections.
    Bagga A, Mantan M.
    Pediatr Nephrol; 2003 May; 18(5):479-80; author reply 481. PubMed ID: 12687462
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.